Describing acute coronary syndrome symptom information on social media platforms
John R Blakeman1, Nathan Carpenter2, Susana J Calderon1
1Mennonite College of Nursing, Illinois State University, Campus Box 5810, Normal, IL 61790-5810, USA.
Background:
Social media is a common source of health-related information. However, more clarity regarding ACS symptom information posted on social media is needed.
Objectives:
The objective was to describe ACS symptom information on social media platforms, including Twitter (now named X), Instagram, and TikTok.
Methods:
A cross-sectional, qualitative descriptive design was used. The three social media platforms were searched in 2022 for posts containing ACS symptom information. A random sample of posts meeting inclusion was drawn. Posts were analyzed using a qualitative coding process, and network analysis was used to triangulate data.
Results:
Posts (N = 342) included in the final analysis were most often published by healthcare organizations (46.2 %), lay persons (20.8 %), or healthcare professionals (13.7 %). Five key themes were identified: 1) a focus on gendered symptom experiences, 2) diverse types of symptom messages (educational, emphasis on getting help, personal testimony, advertising, diagnostic help, research findings), 3) variety of specific symptoms mentioned, 4) different dimensions of symptoms included, and 5) varying levels of information quality and accuracy. Chest pain was the most common ACS symptom highlighted in posts, and symptom differences between men and women were often emphasized.
Conclusions:
Of particular concern was incorrect or misleading ACS symptom information on social media that could create misconceptions and contribute to delays in seeking care for ACS. The findings from this study provide more insight into the ACS symptom information shared on social media platforms and provide preliminary information that can influence practice and future research.
More Related Videos
Related Concept Videos
01:17Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...